Lifeboat Foundation

The TRISO-X, LLC Fuel Fabrication Facility (TF3) will be the nation’s first High-Assay, Low-Enriched Uranium (HALEU) fuel fabrication facility. TRISO-X is a wholly owned subsidiary of advanced reactor designer X-energy, LLC. TF3 will use uranium enriched between 5% and 20% to produce fuel for advanced and small modular reactors of the future. TF3 will manufacture TRi-structural ISOtropic (TRISO) fuel, an advanced fuel that is tough enough to handle the higher operating temperatures of several advanced reactors under development.

The U.S. Department of Energy (DOE) is supporting the development of TF3 through an award with X-energy, LLC under the Advanced Reactor Demonstration Program (ARDP) 0, which aims to speed the demonstration of advanced reactors through cost-shared partnerships with the U.S. nuclear industry. The design and license application development of TF3 was also supported through an $18M (federal cost share) industry FOA that was awarded to X-energy in 2018. TF3 will initially provide the TRISO fuel for X-energy’s Xe-100 high-temperature gas reactor.

“The TRISO-X Fuel Fabrication Facility represents the intersection of some of DOE’s hard work to bring advanced reactors to commercialization,” said Alice Caponiti, DOE’s Deputy Assistant Secretary for Reactor Fleet and Advanced Reactor Deployment. “We’ve been investing in R&D on TRISO fuels for decades. Now, with funding through ARDP, TF3 will bring the next evolution of nuclear fuel to reality, advancing new nuclear technology, creating new jobs, and supporting the clean energy economy.”

ROBOTS are predicted to rule the world by the 2060s, a survey found.

That is forecast to be the peak of Artificial Intelligence capability — with machines in control of politics and economics.

And it is feared that humans’ only role will be to entertain or work for the robots, which will have developed emotions and opinions.

Reimagining Nuclear Medicine — Dr. Stephen Moran, Ph.D., Global Program Head, Neuroendocrine Tumors & Other Radiosensitive Cancers, Advanced Accelerator Applications, Novartis

Dr. Stephen Moran, Ph.D., is Global Program Head, Neuroendocrine Tumors & Other Radiosensitive Cancers, for Advanced Accelerator Applications (AAA — https://www.adacap.com/), a Novartis company and also a member of the Oncology Development Unit Leadership Team at Novartis.

Continue reading “Dr. Stephen Moran, PhD — Reimagining Nuclear Medicine — Advanced Accelerator Applications, Novartis” »

A new report warns that UK government debt is likely to see a major increase this century. The 50-year projections are based on a world of increasing risk, alongside demographic, economic, technological, and other trends.

http://2045.com http://gf2045.com.
In February of 2012 the first Global Future 2045 Congress was held in Moscow. There, over 50 world leading scientists from multiple disciplines met to develop a strategy for the future development of humankind. One of the main goals of the Congress was to construct a global network of scientists to further research on the development of cybernetic technology, with the ultimate goal of transferring a human’s individual consciousness to an artificial carrier.

2012–2013. The global economic and social crises are exacerbated. The debates on the global paradigm of future development intensifies.

Continue reading “2045: A New Era for Humanity” »

For many years, the human genome was seen as a book of life, with passages of remarkable eloquence and economy of expression intermingled with long stretches of nonsense. The readable areas carried the instructions for producing cell proteins; the other regions, which accounted for around 90% of the overall genome, were disregarded as junk DNA

DNA, or deoxyribonucleic acid, is a molecule composed of two long strands of nucleotides that coil around each other to form a double helix. It is the hereditary material in humans and almost all other organisms that carries genetic instructions for development, functioning, growth, and reproduction. Nearly every cell in a person’s body has the same DNA. Most DNA is located in the cell nucleus (where it is called nuclear DNA), but a small amount of DNA can also be found in the mitochondria (where it is called mitochondrial DNA or mtDNA).

China is emerging as a pioneer in artificial intelligence as it makes strides in filing AI patents and experimenting with the latest AI technology to power industrial applications, industry experts said.

Their comments came after a Stanford University report that shows China filed more than half of all the world’s AI patent applications last year and Chinese researchers produced about one-third of AI journal papers and AI citations in 2021.

Wu Hequan, an academician at the Chinese Academy of Engineering, said China has been working to build a solid foundation to support its AI economy and is making significant contributions to AI globally.

ON THE PANEL…

Alys Denby, Deputy Editor, CapX
Mark Johnson, Legal and Policy Officer, Big Brother Watch.
Christopher Snowdon, Head of Lifestyle Economics, IEA
Victoria Hewson, Head of Regulatory Affairs, IEA

Continue reading “Live With(out) Littlewood | Alys Denby, Mark Johnson, Christopher Snowdon + more! | Ep.66” »

After announcing at the beginning of the month that the company would be cutting 10 percent of its workforce due to CEO Elon Musks’s “bad feeling” about the economy, Tesla’s job slash is in full swing. According to Insider, many newer employees — including workers who had not even begun their newly-accepted positions just yet — are bearing the brunt of the mass layoffs.

“Damn, talk about a gut punch,” wrote Iain Abshier, a brand-new Tesla recruiter, in a LinkedIn post last week. “Friday afternoon I was included in the Tesla layoffs after just two weeks of work.”

Continue reading “As Crisis Deepens, Tesla Rescinds Job Offers to People Who’d Already Accepted Them” »